**Core Concept**
Respiratory distress syndrome (RDS) in preterm babies is primarily caused by a deficiency of surfactant, a complex mixture of lipids and proteins that reduces surface tension within the lungs. This deficiency leads to impaired lung expansion and gas exchange, resulting in respiratory distress. The key cell type responsible for surfactant production is the type II pneumocyte.

**Why the Correct Answer is Right**
Type II pneumocytes are specialized cells found in the alveoli that synthesize and secrete surfactant. Surfactant is essential for reducing the surface tension within the lungs, allowing for easy lung expansion and gas exchange during inhalation. In preterm babies, the surfactant production is often insufficient due to the immaturity of type II pneumocytes. This deficiency leads to RDS, characterized by difficulty breathing, granting, and cyanosis.

**Why Each Wrong Option is Incorrect**
* **Option A:** Type I pneumocytes are primarily involved in gas exchange and do not produce surfactant. They are not responsible for surfactant production in preterm babies with RDS.
* **Option B:** Macrophages are immune cells that play a role in phagocytosing foreign particles and bacteria. They are not directly involved in surfactant production.
* **Option D:** Fibroblasts are cells involved in producing collagen and other connective tissue components. They are not responsible for surfactant production in the lungs.

**Clinical Pearl / High-Yield Fact**
Preterm babies with RDS often require surfactant replacement therapy, which can significantly improve their respiratory status and outcomes. It's essential to recognize the role of type II pneumocytes in surfactant production and the pathophysiology of RDS in preterm babies.

**Correct Answer:** C.